Cargando…

Harnessing dendritic cells in inflammatory skin diseases

The skin immune system harbors a complex network of dendritic cells (DCs). Recent studies highlight a diverse functional specialization of skin DC subsets. In addition to generating cellular and humoral immunity against pathogens, skin DCs are involved in tolerogenic mechanisms to ensure the mainten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Chung-Ching, Di Meglio, Paola, Nestle, Frank O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235550/ https://www.ncbi.nlm.nih.gov/pubmed/21295490 http://dx.doi.org/10.1016/j.smim.2011.01.006

Ejemplares similares

Resident CD141 (BDCA3)(+) dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation
por: Chu, Chung-Ching, et al.
Publicado: (2012)

Human skin CD141(+) dendritic cells regulate cutaneous immunity via the neuropeptide urocortin 2
por: Lui, Prudence PokWai, et al.
Publicado: (2023)

The role of IL-23 in the immunopathogenesis of psoriasis
por: Meglio, Paola Di, et al.
Publicado: (2010)

Harnessing Dendritic Cells for Tumor Antigen Presentation
por: Nierkens, Stefan, et al.
Publicado: (2011)

Activation of the Aryl Hydrocarbon Receptor Dampens the Severity of Inflammatory Skin Conditions
por: Di Meglio, Paola, et al.
Publicado: (2014)

Harnessing the properties of dendritic cells in the pursuit of immunological tolerance
por: Horton, Christopher, et al.
Publicado: (2017)

Harnessing human plasmacytoid dendritic cells as professional APCs
por: Tel, Jurjen, et al.
Publicado: (2012)

The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
por: Di Meglio, Paola, et al.
Publicado: (2011)

Characterization of innate lymphoid cells (ILC) in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis
por: Villanova, Federica, et al.
Publicado: (2013)

Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy
por: Amon, Lukas, et al.
Publicado: (2020)

Editorial: Harnessing the Participation of Dendritic Cells in Immunity and Tolerance
por: Boscardin, Silvia Beatriz, et al.
Publicado: (2020)

SL-HarDNet: Skin lesion segmentation with HarDNet
por: Bai, Ruifeng, et al.
Publicado: (2023)

Harnessing Regulatory T Cells for the Treatment of Inflammatory Bowel Disease
por: Geem, Duke, et al.
Publicado: (2015)

Human skin dendritic cells in health and disease
por: Haniffa, Muzlifah, et al.
Publicado: (2015)

Towards a Cure for HARS Disease
por: Wilhelm, Sarah D. P., et al.
Publicado: (2023)

CYP1A1 Enzymatic Activity Influences Skin Inflammation Via Regulation of the AHR Pathway
por: Kyoreva, Mariela, et al.
Publicado: (2021)

Lyoplate-based multiparameter flow cytometry for the analysis of T cell subsets in human immuno-monitoring studies
por: Villanova, Federica, et al.
Publicado: (2011)

Harnessing the early post-injury inflammatory responses for cardiac regeneration
por: Cheng, Bill, et al.
Publicado: (2017)

Moisturizer in Patients with Inflammatory Skin Diseases
por: Kang, Seok-Young, et al.
Publicado: (2022)

Harnessing the gatekeepers of glucocorticoids for chemoprevention of non‐melanoma skin cancer
por: Mancha‐Ramirez, Anna M., et al.
Publicado: (2018)

Harnessing the Potential of Stem Cells for Disease Modeling: Progress and Promises
por: Argentati, Chiara, et al.
Publicado: (2020)

Recurrent Indeterminate Dendritic Cell Tumor of the Skin
por: Joo, Jin Woo, et al.
Publicado: (2018)

Discovery and validation of immunological biomarkers using an advanced flow cytometry platform
por: Villanova, F, et al.
Publicado: (2010)

Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis
por: Andres-Ejarque, Rosa, et al.
Publicado: (2021)

Harnessing NKT cells for vaccination
por: Burn, Olivia K, et al.
Publicado: (2021)

Aquaporins Are One of the Critical Factors in the Disruption of the Skin Barrier in Inflammatory Skin Diseases
por: Tricarico, Paola Maura, et al.
Publicado: (2022)

Harnessing NK Cells to Control Metastasis
por: Deng, Xuewen, et al.
Publicado: (2022)

Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
por: Theron, Annette J, et al.
Publicado: (2013)

Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease
por: Sherman, David J., et al.
Publicado: (2020)

Harnessing RKIP to Combat Heart Disease and Cancer
por: Lorenz, Kristina, et al.
Publicado: (2022)

Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy
por: Tullett, Kirsteen M., et al.
Publicado: (2014)

Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy
por: Mathan, Till S.M., et al.
Publicado: (2017)

The Origin of Skin Dendritic Cell Network and Its Role in Psoriasis
por: Kim, Tae-Gyun, et al.
Publicado: (2017)

Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis
por: Andres-Ejarque, Rosa, et al.
Publicado: (2021)

Harnessing the Therapeutic Potential of Th17 Cells
por: Bystrom, Jonas, et al.
Publicado: (2015)

Features of the Skin Microbiota in Common Inflammatory Skin Diseases
por: Ferček, Iva, et al.
Publicado: (2021)

Emerging Role of Dendritic Cell Intervention in the Treatment of Inflammatory Bowel Disease
por: Sun, Donglei, et al.
Publicado: (2022)

Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages
por: Kim, Bi-o, et al.
Publicado: (2019)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
por: Chauhan, Sachin Kumar Singh, et al.
Publicado: (2020)

Harnessing cell reprogramming for cardiac biological pacing
por: Liu, Chih-Min, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r48s6725cse6vm0185cp2d10jo